Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123

doi:10.3390/ph18071011

Published Erratum

. 2025 Jul 7;18(7):1011.

doi: 10.3390/ph18071011.

Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123

Osama A Mohammed¹, Mustafa Ahmed Abdel-Reheim^{2

3}, Lobna A Saleh^{4

5}, Mohannad Mohammad S Alamri⁶, Jaber Alfaifi⁷, Masoud I E Adam⁸, Alshaimaa A Farrag^{9

10}, AbdulElah Al Jarallah AlQahtani¹¹, Waad Fuad BinAfif¹², Abdullah A Hashish^{13

14}, Sameh Abdel-Ghany¹⁵, Elsayed A Elmorsy^{15

16}, Hend S El-Wakeel^{17

18}, Ahmed S Doghish^{19

20}, Rabab S Hamad^{21

22}, Sameh Saber²³

Affiliations

¹ Department of Clinical Pharmacology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
² Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia.
³ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef 62521, Egypt.
⁴ Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
⁵ Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.
⁶ Department of Family Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
⁷ Department of Child Health, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
⁸ Department of Medical Education and Internal Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
⁹ Department of Histology and Cell Biology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt.
¹⁰ Unit of Anatomy, Department of Basic Medical Sciences, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
¹¹ Department of Internal Medicine, Division of Dermatology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
¹² Department of Internal Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
¹³ Department of Basic Medical Sciences, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
¹⁴ Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
¹⁵ Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
¹⁶ Pharmacology and Therapeutics Department, Qassim College of Medicine, Qassim University, Buraydah 51452, Saudi Arabia.
¹⁷ Physiology Department, Benha Faculty of Medicine, Benha University, Benha 13518, Egypt.
¹⁸ Physiology Department, Albaha Faculty of Medicine, Albaha University, Al Baha 65799, Saudi Arabia.
¹⁹ Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo, Cairo 11829, Egypt.
²⁰ Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11231, Egypt.
²¹ Biological Sciences Department, College of Science, King Faisal University, Al Ahsa 31982, Saudi Arabia.
²² Central Laboratory, Theodor Bilharz Research Institute, Giza 12411, Egypt.
²³ Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt.

PMID: 40732368
PMCID: PMC12298533
DOI: 10.3390/ph18071011

Published Erratum

Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123

Osama A Mohammed et al. Pharmaceuticals (Basel). 2025.

. 2025 Jul 7;18(7):1011.

doi: 10.3390/ph18071011.

Authors

Affiliations

¹ Department of Clinical Pharmacology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
² Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia.
³ Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef 62521, Egypt.
⁴ Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt.
⁵ Department of Pharmacology and Toxicology, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia.
⁶ Department of Family Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
⁷ Department of Child Health, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
⁸ Department of Medical Education and Internal Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
⁹ Department of Histology and Cell Biology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt.
¹⁰ Unit of Anatomy, Department of Basic Medical Sciences, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
¹¹ Department of Internal Medicine, Division of Dermatology, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
¹² Department of Internal Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
¹³ Department of Basic Medical Sciences, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia.
¹⁴ Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
¹⁵ Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
¹⁶ Pharmacology and Therapeutics Department, Qassim College of Medicine, Qassim University, Buraydah 51452, Saudi Arabia.
¹⁷ Physiology Department, Benha Faculty of Medicine, Benha University, Benha 13518, Egypt.
¹⁸ Physiology Department, Albaha Faculty of Medicine, Albaha University, Al Baha 65799, Saudi Arabia.
¹⁹ Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo, Cairo 11829, Egypt.
²⁰ Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11231, Egypt.
²¹ Biological Sciences Department, College of Science, King Faisal University, Al Ahsa 31982, Saudi Arabia.
²² Central Laboratory, Theodor Bilharz Research Institute, Giza 12411, Egypt.
²³ Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt.

PMID: 40732368
PMCID: PMC12298533
DOI: 10.3390/ph18071011

Abstract

In the original publication [...].

PubMed Disclaimer

Figures

**Figure 2**
Effect of the alvespimycin, OLPN, and their combined therapy on the histological structure of the lung. Sections of CTRL (A), 17-DMAG (B), and OLPN (C), respectively, show normal lung architecture formed of thin-walled alveoli. Section of BLCN-treated rats (D) shows substantial inflammatory cellular infiltration (asterisk) and marked thickening of inter-alveolar septa (forked arrow) compared to CTRL, 17-DMAG, or OLPN rats. Lung sections from rats with pulmonary fibrosis treated with 17-DMAG (E), OLPN (F), and their combined therapy (G) reveal mild inflammatory cellular infiltration and alveolar septal thickening (forked arrows) as confirmed by the inflammation score (H). Significance is indicated by the pairwise comparisons. * p < 0.05 vs. BLCN; *** p < 0.001 vs. CTRL.

See this image and copyright information in PMC

Erratum for

Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach.
Mohammed OA, Abdel-Reheim MA, Saleh LA, Alamri MMS, Alfaifi J, Adam MIE, Farrag AA, AlQahtani AAJ, BinAfif WF, Hashish AA, Abdel-Ghany S, Elmorsy EA, El-Wakeel HS, Doghish AS, Hamad RS, Saber S. Mohammed OA, et al. Pharmaceuticals (Basel). 2023 Aug 9;16(8):1123. doi: 10.3390/ph16081123. Pharmaceuticals (Basel). 2023. PMID: 37631038 Free PMC article.

References

1. Mohammed O.A., Abdel-Reheim M.A., Saleh L.A., Alamri M.M.S., Alfaifi J., Adam M.I.E., Farrag A.A., AlQahtani A.A.J., BinAfif W.F., Hashish A.A., et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals. 2023;16:1123. doi: 10.3390/ph16081123. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- MDPI
- PubMed Central

[1] Mohammed O.A., Abdel-Reheim M.A., Saleh L.A., Alamri M.M.S., Alfaifi J., Adam M.I.E., Farrag A.A., AlQahtani A.A.J., BinAfif W.F., Hashish A.A., et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals. 2023;16:1123. doi: 10.3390/ph16081123. - DOI - PMC - PubMed

[2] Mohammed O.A., Abdel-Reheim M.A., Saleh L.A., Alamri M.M.S., Alfaifi J., Adam M.I.E., Farrag A.A., AlQahtani A.A.J., BinAfif W.F., Hashish A.A., et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals. 2023;16:1123. doi: 10.3390/ph16081123. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123

Affiliations

Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123

Authors

Affiliations

Abstract

Figures

Erratum for

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources

Abstract

Figures

Erratum for

Similar articles

References

Publication types

Related information

LinkOut - more resources

Full Text Sources